Maria Sklodowska-Curie Institute – Oncology Centre (MSCI), branch in Gliwice, is a medical research institute conducting research in different fields of oncology and biomedicine. The scientific staff of the Institute consists of more than 120 researchers, including about 30 professors and about 80 PhD or MD/PhD researchers.
MSCI uses its expertise to continuously innovate its ETF and index products. For example, it offers indexes that target systemic style factors, including volatility, size, momentum, and value.
Any market covered by MSCI needs to exhibit at least some accessibility by international institutional investors to be eligible for designation as a Stand-Alone Market. The MSCI Standalone Market Indexes are not included in the MSCI Emerging Markets Index or MSCI Frontier Markets Index.